Generate a tailored SOP for Dr. Van Thai. Improve your application with a focused, well-structured draft.
Van Thai is a medical microbiologist with a strong interest in deciphering antimicrobial resistance (AMR) using genomic and proteomic approaches, developing novel therapeutic interventions. His research focuses on AMR mechanisms in Staphylococcus aureus, Pseudomonas aeruginosa, Neisseria gonorrhoeae, and Neisseria meningitidis. From 2016 to 2019, he gained industry experience at Rohto-Mentholatum in Vietnam, contributing to the development of treatments for bacterial infections such as sinusitis. He completed his PhD at the University of Western Australia (UWA) in June 2024, where he pioneered innovative strategies to combat multi-drug resistant N. gonorrhoeae, developing a high-throughput drug screening assay using AMNIS flow cytometry targeting MCR-1, an enzyme conferring resistance to the last-line antibiotic polymyxin. Currently, as a Postdoctoral Research Associate at the Marshall Centre for Infectious Diseases at UWA, Van is dedicated to advancing healthcare innovation against high-priority bacterial pathogens, with his current research focusing on elucidating AMR mechanisms in N. meningitidis and developing novel diagnostic tools to detect resistance in this pathogen.
Marshall Centre for Infectious Diseases • Perth, Australia
Conducting research on antimicrobial resistance and developing novel therapeutic interventions.
Requirements are standardized across the Graduate School for most Master by Coursework programs at UWA.